Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

CRISPR base editing as a potential therapeutic approach for Kir7.1 channelopathy

Meha Kabra; Pawan K Shahi; ALLISON SPILLANE; Yuyuan Wang; Divya Sinha; Gregory A Newby; Shivani Saxena; Krishanu Saha; Mariya Moosajee; David Gamm; David R. Liu; Shaoqin Gong; Bikash R Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1483. doi:

ARVO Annual Meeting Abstract June 2020

CRISPR Base Editing; A feasible treatment for inherited retinopathy

Meha Kabra; Allison Spillane; Pawan Shahi; David M Gamm; Amr A Abdeen; Krishanu Saha; Bikash R Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2451. doi:

ARVO Annual Meeting Abstract June 2020

Genome-Edited LCA16 iPSC-RPE Shows Rescue of Kir7.1 Channel

Pawan Shahi; Meha Kabra; Amr A Abdeen; Yuyuan Wang; Kim Edwards; Divya Sinha; David M Gamm; Krishanu Saha; Sarah Gong; Bikash R Pattnaik

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2453. doi:

ARVO Annual Meeting Abstract July 2019

Gene therapies differentially rescue disease phenotype in patient-specific hiPSC-RPE models of Best disease

Divya Sinha; Benjamin Steyer; Pawan K Shahi; Rasa Valiauga; Kimberly L Edwards; Cole Bacig; Bikash R Pattnaik; Krishanu Saha; David M Gamm

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3390. doi:

ARVO Annual Meeting Abstract July 2019

Precise and Safe Gene Editing in Retinal Pigment Epithelial Cells in vivo

Bikash R Pattnaik; Pawan K Shahi; Guojun Chen; Amr A Abdeen; Yuyuan Wang; Krishanu Saha; Shaoqin Gong

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4942. doi:

Advertisement